VITAL THERAPIES INC (57)
Browse by Contract Category
Contracts
-
Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof
(Filed With SEC on January 20, 2023)
-
Addendum No. 4 to Employment Agreement, dated December 28, 2022, between Immunic, Inc. and Duane Nash
(Filed With SEC on December 30, 2022)
-
Description of Registrant's Securities
(Filed With SEC on November 3, 2022)
-
Securities Purchase Agreement, dated October 10, 2022, by and among the Company and the Purchasers
(Filed With SEC on October 11, 2022)
-
Option and License Agreement, dated September 27, 2018, between Immunic AG and Daiichi Sankyo Company, Limited
(Filed With SEC on July 17, 2019)
-
Lease Assignment Agreement by and between ViaCyte, Inc. and Vital Therapies, Inc
(Filed With SEC on March 19, 2019)
-
Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler
(Filed With SEC on January 20, 2023)
-
Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt
(Filed With SEC on January 20, 2023)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 11, 2022)
-
Description of Registrant's Securities
(Filed With SEC on August 4, 2022)
-
Description of Registrant's Securities
(Filed With SEC on May 10, 2022)
-
Sales Agreement, dated as of May 2, 2022, between SVB Securities LLC and Immunic, Inc
(Filed With SEC on May 2, 2022)
-
Addendum No. 3 to Employment Agreement, dated March 15, 2022, between Immunic, Inc. and Duane Nash
(Filed With SEC on March 16, 2022)
-
Description of Registrant's Securities
(Filed With SEC on February 24, 2022)
-
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Daniel Vitt
(Filed With SEC on January 10, 2022)
-
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Andreas Muehler
(Filed With SEC on January 10, 2022)
-
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Hella Kohlhof
(Filed With SEC on January 10, 2022)
-
Description of Registrant's Securities
(Filed With SEC on November 4, 2021)
-
Employment Agreement, dated October 14, 2021, by Patrick Walsh and Immunic, Inc
(Filed With SEC on October 15, 2021)
-
Description of Registrant's Securities
(Filed With SEC on August 6, 2021)
-
Underwriting Agreement, dated July 15, 2021, by and between Immunic, Inc. and Piper Sandler & Co
(Filed With SEC on July 19, 2021)
-
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Glenn Whaley
(Filed With SEC on June 14, 2021)
-
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Dr. Andreas Muehler
(Filed With SEC on June 14, 2021)
-
Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Andreas Muehler
(Filed With SEC on June 14, 2021)
-
Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Daniel Vitt
(Filed With SEC on June 14, 2021)
-
Description of Registrant's Securities
(Filed With SEC on May 6, 2021)
-
Addendum No. 2 to Employment Agreement, dated April 15, 2021, between Immunic, Inc. and Duane Nash
(Filed With SEC on April 19, 2021)
-
Settlement Agreement, dated March 31, 2021, between Immunic AG and 4SC AG
(Filed With SEC on March 31, 2021)
-
Description of Registrant's Securities
(Filed With SEC on February 26, 2021)
-
Sales Agreement, dated as of December 29, 2020, between SVB Leerink LLC and Immunic, Inc
(Filed With SEC on January 4, 2021)
-
Amendment Letter, dated November 11, 2020
(Filed With SEC on November 13, 2020)
-
Addendum to Employment Agreement dated October 15, 2020, between Immunic, Inc. and Duane Nash
(Filed With SEC on November 6, 2020)
-
Form of Guarantee Agreement between Immunic, Inc., Immunic AG and European Investment Bank
(Filed With SEC on October 20, 2020)
-
Finance Contract, dated October 19, 2020, between Immunic, Inc., Immunic AG and European Investment Bank
(Filed With SEC on October 20, 2020)
-
Underwriting Agreement, dated August 4, 2020, by and between Immunic, Inc. and SVB Leerink LLC
(Filed With SEC on August 10, 2020)
-
Form of Securities Purchase Agreement, dated June 10, 2020, between the Company and the investors party thereto
(Filed With SEC on June 12, 2020)
-
Placement Agency Agreement, dated June 10, 2020, between the Company and the Placement Agent
(Filed With SEC on June 12, 2020)
-
Form of Securities Purchase Agreement, dated April 23, 2020, between the Company and the investors party thereto
(Filed With SEC on April 27, 2020)
-
Letter Agreement, dated April 23, 2020, between the Company and the Placement Agent
(Filed With SEC on April 27, 2020)
-
Employment Agreement dated April 17, 2020
(Filed With SEC on April 20, 2020)
-
Confidential Severance Agreement and Full and General Release dated April 17, 2020
(Filed With SEC on April 20, 2020)
-
Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Manfred Grppel
(Filed With SEC on September 5, 2019)
-
Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Daniel Vitt
(Filed With SEC on September 5, 2019)
-
Sales Agreement, dated as of July 17, 2019, between SVB Leerink LLC and Immunic, Inc
(Filed With SEC on July 17, 2019)
-
Employment Agreement, dated as of July 15, 2019, by and between Sanjay Patel and Immunic, Inc
(Filed With SEC on July 17, 2019)
-
Grppel Employment Agreement, dated as of August 26, 2016, by and between Dr. Manfred Grppel and Immunic AG
(Filed With SEC on July 17, 2019)
-
Vitt Employment Agreement, dated as of March 23, 2016, by and between Dr. Daniel Vitt and Immunic AG
(Filed With SEC on July 17, 2019)
-
Form of Indemnification Agreement
(Filed With SEC on July 17, 2019)
-
Asset Purchase Agreement, dated May 13, 2016, between Immunic AG and 4SC AG
(Filed With SEC on July 17, 2019)
-
Forms of Lock-Up Agreement
(Filed With SEC on April 15, 2019)
-
Second Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of April 4, 2019
(Filed With SEC on April 10, 2019)
-
First Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of March 27, 2019
(Filed With SEC on April 10, 2019)
-
Asset Purchase Agreement by and between RH Cell Therapeutics Corp and Vital Therapies, Inc., dated March 13, 2019
(Filed With SEC on March 19, 2019)
-
Form of Amendment No. 1 to Change of Control and Severance Agreement
(Filed With SEC on January 14, 2019)
-
Form of RSU Award Agreement under 2014 Equity Incentive Plan
(Filed With SEC on January 14, 2019)
-
Exchange Agreement, dated as of January 6, 2019 by and among Vital Therapies, Inc., Immunic AG, and the shareholders of Immunic AG
(Filed With SEC on January 7, 2019)
-
Investment and Subscription Agreement, dated as of January 6, 2019, among Immunic AG and its Shareholders
(Filed With SEC on January 7, 2019)